NOS3 and fetal growth restriction: The decreased NO bioavailability in the first trimester of pregnancy, is a cause of poor placentation [8], [9], [10], [11], [13], while eNOS deficiency is associated with reduced placental vascularization and fetal growth restriction in homozygous eNOS-/- conceptus, but not in heterozygous [44].